SCHEMBL9975608

SCHEMBL9975608

CCOC(=O)c1ccc(N(C)c2csc(-c3ccc(C)cc3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.46
RARA P10276 1/20 0.46
RARB P10826 1/20 0.46
RARG P13631 1/20 0.46
RAB9A P51151 5/20 0.45
GAA P10253 2/20 0.45
MAPT P10636 5/20 0.43
ALDH1A1 P00352 2/20 0.43
NPC1 O15118 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9975605 0.91 MAPT (0.48) TRPM8RARARARBRARGRAB9A
SCHEMBL8238620 0.91 RARA (0.54) TRPM8RARARARBRARGRAB9A
SCHEMBL8242411 0.88 MAPT (0.51) RARARARBRARGRAB9AGAA
SCHEMBL9975603 0.79 SMN1; SMN2 (0.47) TRPM8RARARARBRARGRAB9A
SCHEMBL8239693 0.79 RARA (0.53) TRPM8RARARARBRARGRAB9A
SCHEMBL8239864 0.78 RARA (0.52) TRPM8RARARARBRARGRAB9A
SCHEMBL9975604 0.77 RARA (0.51) TRPM8RARARARBRARGRAB9A
SCHEMBL9975610 0.76 SREBF2 (0.56) RAB9AMAPTALDH1A1NPC1L3MBTL1
SCHEMBL12582252 0.75 RAB9A (0.72) TRPM8RAB9AGAAMAPTALDH1A1
SCHEMBL12544707 0.74 CA12 (0.56) RAB9AGAAMAPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394798-B2 Compositions and methods for inducing neuronal differentiation THE SCRIPPS RESEARCH INSTITUTE (US) 2013-03-12 US disclosed
US-20120157457-A1 COMPOSITIONS AND METHODS FOR INDUCING NEURONAL DIFFERENTIATION THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157457-A1 COMPOSITIONS AND METHODS FOR INDUCING NEURONAL DIFFERENTIATION CHAT, DCX, GAP43 TRPM8 3626/4885RARA 163/4885RARB 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.